This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, the pharma/biopharma industry overall shows stagnant R&D activity. growth from 2023 to 2024. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%. increase from 2022. Total R&D expenditure is approximately $276.81 billion, with a modest 2.5%
However, the pharma/biopharma industry shows overall stagnant R&D activity. growth from 2023 to 2024. What is driving transformation in the pharma industry? Small-to-mid and emerging biopharma players contribute over 16%. increase from 2022. Total R&D expenditure is approximately $276.81 billion, with a modest 2.5%
With 87% of biopharma manufacturers targeting renewable electricity by 2030, CDMOs must align with evolving sustainability regulations and partner expectations. Strengthening Supply Chain Resilience In 2024, US drug shortages hit 277, highlighting the vulnerabilities in pharmaceutical supply chains.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2024 
52 
Let's personalize your content